These results suggest that inhibition of PI3K and STAT5 by GDC-0941 and pimozide, respectively, synergistically suppressed the 4EBP1/Mcl-1 pathway leading to reduction in viability of primary AML cells expressing FLT3-ITD. This evidence concerns the gene MCL1 and acute myeloid leukemia.